Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Wednesday, April 24, 2019
Show Filter
7:30am - 8:30am 60 mins
Registration & Networking Breakfast
8:30am - 8:45am 15 mins
Opening Remarks
8:45am - 9:15am 30 mins
Opening Keynote Address
  • Keynote Speaker George Q. Daley - Dean of the Faculty of Medicine, Harvard Medical School
9:15am - 9:45am 30 mins
Assessing the Value of Innovation in Oncology

Examine the current obstacles in pricing, reimbursement, access and the healthcare & life sciences infrastructure. What is the current “state of play”? And perhaps most importantly, understand the changes in outcome for patients and the patient perspective.  

  • Contributor Deborah Morosini - Vice President of Clinical Affairs and Patient Engagement, Loxo Oncology
9:45am - 10:15am 30 mins
Fireside Chat: Breakthroughs in Novel Oncology Drug Development

Examine & Understand the impact of the growing industry pipeline, the evolution of clinical trial landscape and access to available real-world data on Oncology & therapeutic development

  • Contributor Marion Dorsch - Chief Scientific Officer, Blueprint Medicines
10:15am - 10:45am 30 mins
Networking Break
10:45am - 11:15am 30 mins
Commercializing New Therapeutic Pathways

Gain insight into evolving market access and commercialization models that optimize strategy and ensure patient access to new therapies. How do you differentiate your therapeutic in a crowded space? Explore the need for more therapeutics for current unmet needs.

  • Contributor Sophie Opdyke - Vice President, Immuno-Oncology Lead, Global Commercial Development, Pfizer
11:15am - 11:30am 15 mins
Strategic Immuno-Oncology Collaboration: Spotlight on Tango Therapeutics

A look at a creative global collaboration to develop & commercialize Immuno-Oncology treatments. 

  • Contributor Shakti Narayan - CBO, Tango Therapeutics
11:30am - 12:00pm 30 mins
Therapeutic Market Focus: Immuno-Oncology
  • Contributor Pamela Contag - Chief Executive Officer, Founder and Board Director, BioEclipse Therapeutics
  • Contributor Arthur Krieg, - Founder & CSO, Checkmate Pharmaceuticals
12:00pm - 12:30pm 30 mins
The Evolving Role of Biomarkers & Diagnostic

Understand how diagnostics are enabling a more targeted approach to treat an increasing number of cancers.

  • Contributor Elizabeth O'Day - CEO & Founder, Olaris Therpeutics
  • Contributor Andrew Beck - Co-Founder & CEO, PathAI
12:30pm - 1:00pm 30 mins
Investor/Founder Keynote Chat
1:00pm - 2:00pm 60 mins
Networking Lunch
2:00pm - 2:30pm 30 mins
New Target Spaces What's beyond IO?
  • Contributor Michael Zinda - Executive Vice President, Head of Research and Development, Repare Therapeutics
2:30pm - 2:45pm 15 mins
Spotlight- AI & Drug Discovery

How do you separate the hype from reality in today Drug Discovery? Cloud Pharmaceuticals is the leader of AI-based (augmented by data mining and computational chemistry) drug design and development. We will showcase here AI deployment and automation while maintaining chemical information that is crucial for drug discovery.

  • Contributor Shahar Keinan - CEO and Co-Founder, Cloud Pharmaceuticals
2:45pm - 3:15pm 30 mins
Keynote Chat: Is AI the cure for Cancer?
  • Keynote Speaker Marty Tenenbaum - Founder & Chairman, Cancer Commons
3:15pm - 3:45pm 30 mins
Networking Break
3:45pm - 4:15pm 30 mins
Fireside Chat: Personalizing Cancer & It’s Treatment

How will customizing treatments to individual needs impact the patient journey and treatment?

  • Contributor Rangaprasad Sarangarajan - SVP & CSO, BERG
  • Contributor Roman Yelensky - EVP & CTO, Gritstone Oncology
4:15pm - 4:45pm 30 mins
Therapeutic Focus: Oncolytic Viruses

Explore how Oncolytic Viruses will increase the chances that patients will respond to Immunotherapies. 

  • Contributor Theodore (Ted) T. Ashburn - President and CEO, Oncorus, Inc.
4:45pm - 5:15pm 30 mins
Closing Keynote Moderated Chat
5:15pm - 5:30pm 15 mins
Closing Remarks
5:30pm - 6:30pm 60 mins
Cocktail Reception